Nanoparticle‑based antiviral strategies to combat the influenza virus (Review)

Biomed Rep. 2024 Feb 21;20(4):65. doi: 10.3892/br.2024.1753. eCollection 2024 Apr.

Abstract

The rapid availability of effective antiviral treatments would be beneficial during the early phases of a pandemic, as they could reduce viral loads and control serious infections until antigenic vaccines become widely available. One promising alternative therapy to combat pandemics is nanotechnology, which has the potential to inhibit a wide variety of viruses, including the influenza virus. This review summarizes the recent progress using gold, copper, silver, silicone, zinc and selenium nanoparticles, since these materials have shown remarkable antiviral capacity against influenza A virus.

Keywords: antivirals; influenza A virus; nanomedicine; nanoparticles.

Publication types

  • Review

Grants and funding

Funding: Financial support was provided by the Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCYT) [Ciencia de Frontera (grant no. 1715645 to JBM) and postdoctoral fellowship (2022-1) (grant no. 2306495 to CPRI)].